| Medical Condition | Cardiovascular Disease |
| Facility/Clinic | 1124 Gallery Park Boulevard |
| Age | 18 years old and up |
| Gender | Male & Female |
| Description | This is a Phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, and safety of relacorilant to treat hypercortisolism in patients with cortisol-secreting adrenal adenoma or hyperplasia associated with diabetes mellitus/impaired glucose tolerance and/or uncontrolled systolic hypertension. |
| Enrollment | Open |
| Patient Commitment Duration | 4 months |
| Number of visits in study | 6 in person visits |
| Patient Compensation | $100 per visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-362-4040 between the hours of 8am-5pm for general research questions.